In pre-clinical trials, drug shows potential to combat exaggerated inflammation associated with COVID-19
What causes severe COVID symptoms? Research examines role of immune systems
21 October 2022Flexible surgical needle offers enhanced precision
21 October 2022In pre-clinical trials, drug shows potential to combat exaggerated inflammation associated with COVID-19
Experiments involving animals and human cells conducted at the University of São Paulo (USP) in Brazil suggest that niclosamide, an anthelmintic widely used against tapeworms, effectively inhibits SARS-CoV-2 replication as well as the exacerbated inflammatory response that leads to death in many patients with severe COVID-19.
